Disclosures for "Diagnostic Yield of Genetic Testing in Adults with Epilepsy"
-
Miss Copeland has nothing to disclose.
-
Mr. Baldwin has nothing to disclose.
-
Mrs. Raper has nothing to disclose.
-
Ms. Helbig has nothing to disclose.
-
Ms. Sullivan has nothing to disclose.
-
Ms. Ginn has nothing to disclose.
-
The institution of Mrs. Ruggiero has received research support from STXBP1 Disorders Foundation.
-
The institution of Miss Lusk has received research support from NIH. The institution of Miss Lusk has received research support from CACNA1A Foundation.
-
Ms. Cohen has nothing to disclose.
-
Ms. Back has nothing to disclose.
-
Dr. Fitzgerald has nothing to disclose.
-
Dr. Massey has a non-compensated relationship as a consultant with Sun Pharmaceutical Ltd that is relevant to AAN interests or activities.
-
Dr. Pojomovsky McDonnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Pojomovsky McDonnell has received research support from AAN.
-
Dr. Goldberg has nothing to disclose.
-
Dr. Helbig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Encoded. Dr. Helbig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Helbig has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder.